Immune complexes formed following the binding of anti platelet factor 4 (CXCL4) antibodies to CXCL4 stimulate human neutrophil activation and cell adhesion

Blood

Volumn 112, Issue 4, 2008, Pages 1091-1100

  Xiao, Zhihua ^a   Visentin, Gian P ^b   Dayananda, Kannayakanahalli M ^a   Neelamegham, Sriram ^a,c  

^a the State University of New York   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD16 ANTIGEN; CD18 ANTIGEN; CD32 ANTIGEN; CHONDROITIN ABC LYASE; CHONDROITIN SULFATE; FC RECEPTOR IIA; IMMUNOGLOBULIN G; L SELECTIN; THROMBOCYTE FACTOR 4; FC RECEPTOR; HEPARIN; MONOCLONAL ANTIBODY;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL SURFACE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DEGRANULATION; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN CELL; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; UPREGULATION; ANIMAL; ANTIGEN ANTIBODY REACTION; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; CHEMISTRY; IMMUNOLOGY; LEUKOCYTE; METABOLISM; PHYSIOLOGY; RAT; THROMBOCYTOPENIA;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-ANTIBODY COMPLEX; ANTIGEN-ANTIBODY REACTIONS; CELL ADHESION; CHONDROITIN SULFATES; HEPARIN; HUMANS; LEUKOCYTES; NEUTROPHIL ACTIVATION; PLATELET FACTOR 4; RATS; RECEPTORS, IGG; THROMBOCYTOPENIA;

EID: 51649114878     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-04-153288     Document Type: Article

References (43)

1. von Hundelshausen P, Petersen F, Brandt E. Platelet-derived chemokines in vascular biology. Thromb Haemost. 2007;97:704-713.
2. Zucker MB, Katz IR. Platelet factor 4: production, structure, and physiologic and immunologic action. Proc Soc Exp Biol Med. 1991;198:693-702.
3. Cines DB, Tomaski A, Tannenbaum S. Immune endothelial-cell injury in heparin-associated thrombocytopenia. N Engl J Med. 1987;316:581- 589.
4. Visentin GP, Ford SE, Scott JP, Aster RH. Antibodies from patients with heparin-induced throm- bocytopenia/thrombosis are specific for platelet factor 4 complexed with heparin or bound to endothelial cells. J Clin Invest. 1994;93:81-88.
5. Lasagni L, Grepin R, Mazzinghi B, et al. PF-4/ CXCL4 and CXCL4L1 exhibit distinct subcellular localization and a differentially regulated mechanism of secretion. Blood. 2007;109:4127-4134.
6. Mayo KH, Ilyina E, Roongta V, et al. Heparin binding to platelet factor-4: an NMR and site- directed mutagenesis study: arginine residues are crucial for binding. Biochem J. 1995;312(pt2):357-365.
7. Petersen F, Bock L, Flad HD, Brandt E. Achon- droitin sulfate proteoglycan on human neutrophils specifically binds platelet factor 4 and is involved in cell activation. J Immunol. 1998;161:4347-4355.
8. Warkentin TE. Think of HIT. HematologyAm Soc Hematol Educ Program. 2006;408-414.
9. Poncz M. Mechanistic basis of heparin-induced thrombocytopenia. Semin Thorac Cardiovasc Surg. 2005;17:73-79.
10. Amiral J, Bridey F, Dreyfus M, et al. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia. Thromb Haemost. 1992;68:95-96.
11. Newman PM, Chong BH. Heparin-induced throm- bocytopenia: new evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation. Blood. 2000;96:182-187.
12. Rauova L, Zhai L, Kowalska MA, Arepally GM, Cines DB, Poncz M. Role of platelet surface PF4 antigenic complexes in heparin-induced thrombo- cytopenia pathogenesis: diagnostic and therapeutic implications. Blood. 2006;107:2346-2353.
13. Walenga JM, Jeske WP, Messmore HL. Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia. J Thromb Throm- bolysis. 2000;10(suppl 1):13-20.
14. Blank M, Shoenfeld Y, Tavor S, et al. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells. Int Immunol. 2002;14:121-129.
15. Arepally GM, Mayer IM. Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8. Blood. 2001;98:1252-1254.
16. Pouplard C, Iochmann S, Renard B, et al. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia. Blood. 2001;97:3300-3302.
17. Khairy M, Lasne D, Amelot A, et al. Polymorpho- nuclear leukocyte and monocyte activation induced by plasma from patients with heparin- induced thrombocytopenia in whole blood. Thromb Haemost. 2004;92:1411-1419.
18. Zhang Y, Neelamegham S. Estimating the efficiency of cell capture and arrest in flow chambers: study of neutrophil binding via E-selectin and ICAM-1. Biophys J. 2002;83:1934-1952.
19. Suh JS, Aster RH, Visentin GP. Antibodies from patients with heparin-induced thrombocytopenia/ thrombosis recognize different epitopes on heparin: platelet factor 4. Blood. 1998;91:916-922.
20. Poncz M, Surrey S, LaRocco P, et al. Cloning and characterization of platelet factor 4 cDNA derived from a human erythroleukemic cell line. Blood. 1987;69:219-223.
21. Liu CY, Battaglia M, Lee SH, Sun QH, Aster RH, Visentin GP. Platelet factor 4 differentially modulates CD4+CD25+ (regulatory) versus CD4+CD25- (nonregulatory) T cells. J Immunol. 2005;174:2680-2686.
22. Xiao Z, Goldsmith HL, McIntosh FA, Shankaran H, Neelamegham S. Biomechanics of P-selectin PSGL-1 bonds: shear threshold and integrin- independent cell adhesion. Biophys J. 2006;90: 2221-2234.
23. Neelamegham S, Taylor AD, Shankaran H, Smith CW, Simon SI. Shear and time-dependent changes in Mac-1, LFA-1, and ICAM-3 binding regulate neutrophil homotypic adhesion. J Immunol. 2000;164:3798-3805.
24. Smolen JE, Petersen TK, Koch C, et al. L-selectin signaling of neutrophil adhesion and degranulation involves p38 mitogen-activated protein ki- nase. J Biol Chem. 2000;275:15876-15884.
25. Petersen F, Ludwig A, Flad HD, Brandt E. TNF- alpha renders human neutrophils responsive to platelet factor 4: comparison of PF-4 and IL-8 reveals different activity profiles of the two chemo- kines. J Immunol. 1996;156:1954-1962.
26. Visentin GP. Heparin-induced thrombocytopenia: molecular pathogenesis. Thromb Haemost. 1999; 82:448-456.
27. Greinacher A, Potzsch B, Amiral J, Dummel V, Eichner A, Mueller-Eckhardt C. Heparin- associated thrombocytopenia: isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen. Thromb Haemost. 1994;71:247-251.
28. Horne MK III, Hutchison KJ. Simultaneous binding of heparin and platelet factor-4 to platelets: further insights into the mechanism of heparin- induced thrombocytopenia. Am J Hematol. 1998; 58:24-30.
29. Shoup D, Szabo A. Role of diffusion in ligand binding to macromolecules and cell-bound receptors. Biophys J. 1982;40:33-39.
30. Kelton JG, Sheridan D, Santos A, et al. Heparin-induced thrombocytopenia: laboratory studies. Blood. 1988;72:925-930.
31. Sanchez-Mejorada G, Rosales C. Signal transduction by immunoglobulin Fc receptors. J Leukoc Biol. 1998;63:521-533.
32. Luster AD, Alon R, von Andrian UH. Immune cell migration in inflammation: present and future therapeutic targets. Nat Immunol. 2005;6:1182- 1190.
33. Li ZQ, Liu W, Park KS, et al. Defining a second epitope for heparin-induced thrombocytopenia/ thrombosis antibodies using KKO, a murine HITlike monoclonal antibody. Blood. 2002;99:1230-1236.
34. Neelamegham S, Taylor AD, Burns AR, Smith CW, Simon SI. Hydrodynamic shear shows distinct roles for LFA-1 and Mac-1 in neutrophil adhesion to intercellular adhesion molecule-1. Blood. 1998;92:1626-1638.
35. Fareed J, Walenga JM, Hoppensteadt DA, et al. Selectins in the HIT syndrome: pathophysiologic role and therapeutic modulation. Semin Thromb Hemost. 1999;25(suppl 1):37-42.
36. Detmers PA, Lo SK, Olsen-Egbert E, Walz A, Baggiolini M, Cohn ZA. Neutrophil-activating protein 1/interleukin 8 stimulates the binding activity of the leukocyte adhesion receptor CD11b/CD18 on human neutrophils. J Exp Med. 1990;171: 1155-1162.
37. Harter L, Petersen F, Flad HD, Brandt E. Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils: requirement for proteolytic formation of the neutrophil-activating peptide2. J Immunol. 1994;153:5698-5708.
38. Dudek AZ, Nesmelova I, Mayo K, Verfaillie CM, Pitchford S, Slungaard A. Platelet factor 4 promotes adhesion of hematopoietic progenitor cells and binds IL-8: novel mechanisms for modulation of hematopoiesis. Blood. 2003;101:4687-4694.
39. von Hundelshausen P, Koenen RR, Sack M, et al. Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood. 2005;105:924-930.
40. Moore KL, Varki A, McEver RP. GMP-140 binds to a glycoprotein receptor on human neutrophils: evidence for a lectin-like interaction. J Cell Biol. 1991;112:491-499.
41. Forlow SB, McEver RP, Nollert MU. Leukocyte- leukocyte interactions mediated by platelet microparticles under flow. Blood. 2000;95:1317-1323.
42. 2-integrin. Circulation. 1998;98:873-882.
43. Evangelista V, Manarini S, Sideri R, et al. Platelet/ polymorphonuclear leukocyte interaction: P- selectin triggers protein-tyrosine phosphorylation- dependent CD11b/CD18 adhesion: role of PSGL-1 as a signaling molecule. Blood. 1999;93:876-885.